title: Valacyclovir neurotoxicity in a patient with end-stage renal disease treated with continuous ambulatory peritoneal dialysis.
authors.forename: T
authors.initials: T
authors.lastname: Okada
authors.forename: T
authors.initials: T
authors.lastname: Nakao
authors.forename: H
authors.initials: H
authors.lastname: Matsumoto
authors.forename: Y
authors.initials: Y
authors.lastname: Nagaoka
authors.forename: H
authors.initials: H
authors.lastname: Iwasawa
authors.forename: K
authors.initials: K
authors.lastname: Nanri
authors.forename: T
authors.initials: T
authors.lastname: Yamazaki
mesh_terms: D000212:Acyclovir / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives*; D000368:Aged; D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000628:therapy*; D008297:Male; D020258:Neurotoxicity Syndromes / Q000209:etiology*; D010531:Peritoneal Dialysis, Continuous Ambulatory; D000077483:Valacyclovir; D014633:Valine / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives*
chemical_list: D000998:Antiviral Agents; D014633:Valine; D000077483:Valacyclovir; D000212:Acyclovir